deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
Analysis of 4 SNPs, in tandem with genetic risk factors detected by the deCODE ProstateCancer test, yields substantial improvement in efficacy of PSA screening
2010-12-16
(Press-News.org) Reykjavik, ICELAND, 15 December 2010 – Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome (SNPs) that impact individual baseline levels of prostate specific antigen, or PSA. Testing for PSA levels is the most commonly used screening tool for the detection of prostate cancer. A prostate biopsy is routinely recommended for men with PSA above a certain threshold. However, PSA levels can rise for reasons unrelated to prostate cancer and baseline healthy levels vary substantially between individuals, resulting in many men without cancer being biopsied while cancer in others is not detected. The paper published today demonstrates that analysis of four SNPs can be used to derive a personalized PSA threshold that more accurately identifies those men who are more likely to have a positive biopsy and for whom one should therefore be recommended.
"This is straighforward genetics with direct clinical utility. Detected early, prostate cancer can be treated with near total success. The challenge is to more effectively risk stratify the population, identifying and biopsying those at high risk and with aggressive disease while minimizing the number of negative biopsies we perform. And using the genetics we are improving the sensitivity and specificity of PSA testing. Like virtually every protein in the body, PSA levels vary between individuals according to SNPs that regulate gene expression. The SNPs reported today enable us to personalize PSA thresholds, thereby changing the recommendation on whether to biopsy for a substantial proportion of men. Moreover, the discriminatory power of testing for these SNPs is highest when done in tandem with the SNPs associated directly with risk of the disease measured by our deCODE ProstateCancer™ test. We are working to swiftly incorporate these PSA markers into our testing portfolio," said Kari Stefansson, CEO of deCODE and senior author on the study.
The paper, entitled "Genetic correction of PSA values using sequence variants associated with PSA levels," is published today online in Science Translational Medicine at www.ScienceTranslationalMedicine.org and will appear in an upcoming print edition of the journal. The study was conducted in several stages and involved tens of thousands of men with and without prostate cancer. First, more than 300,000 SNPs were analyzed in 16,000 Icelandic men with PSA measurements but who had never been diagnosed with prostate cancer. SNPs that correlated with PSA levels were identified and then validated in a cohort from the UK. These SNPs were then studied in large case-control cohorts from Iceland, the Netherlands, Spain, Romania and the US to establish the association with PSA levels independent of risk of prostate cancer itself. The authors then demonstrated how measuring four SNPs correlated with PSA levels can be used to obtain a personalized threshold for when to biopsy, and that using such thresholds improves the ratio of positive to negative biopsies. The greatest improvement in prediction accuracy was seen when men are tested both for the PSA correction SNPs as well as a panel of prostate cancer risk SNPs detected by the deCODE ProstateCancer™ test.
INFORMATION:
deCODE and the authors wish to thank the thousands of participants who took part in this study. It was funded in part by grant 202059 (PROMARK) and grant 218071 (CancerGene), both from the 7th Framework Program of the European Union.
About deCODE
Headquartered in Reykjavik, Iceland, deCODE genetics is a global leader in analyzing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer. deCODE employs its capabilities to develop DNA-based tests and scans to better understand individual risk and empower prevention, and partners its tests, intellectual property and analytical capabilities with companies and research institutions around the globe. Through its CLIA- and CAP-certified laboratory deCODE offers DNA-based tests including deCODE ProstateCancer™; deCODE MI™ for heart attack; deCODE BreastCancer, for the common forms of breast cancer; deCODE AF™ for atrial fibrillation and stroke; deCODE Glaucoma™; and deCODE T2™ for type 2 diabetes. Through its pioneering personal genome analysis service deCODEme™, deCODE enables individuals to better understand their risk of dozens of common diseases and to learn about their ancestry and other traits. Visit us on the web at www.decode.com; for our full range of tests and scans at www.decodehealth.com; at www.decodeme.com; and on our blog at www.decodeyou.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-12-16
America is winning a battle against heart disease and stroke mortality, but is still losing the war, according to the American Heart Association.
In Heart Disease and Stroke Statistics – 2011, published online in Circulation: Journal of the American Heart Association, the association reports that the death rate from heart diseases declined 27.8 percent from 1997 to 2007 (the most recent final data available), and the stroke death rate fell 44.8 percent.
However, during the same period, the total number of inpatient cardiovascular operations and procedures increased ...
2010-12-16
Body fat distribution does not play an important role in the incidence of every subtype of premenopausal breast cancer, but is associated with an increased risk for estrogen receptor (ER)–negative breast cancer, according to a study published December 15 in The Journal of the National Cancer Institute.
Previous studies have shown that the association between body mass index (BMI) and the risk of breast cancer varies with menopausal status: a higher BMI is positively associated with risk of postmenopausal breast cancer but inversely associated with risk of premenopausal ...
2010-12-16
"Staph" bacteria feed on blood. They need the iron that's hidden away inside red blood cells to grow and cause infections. It turns out that these microbial vampires prefer the taste of human blood, Vanderbilt University scientists have discovered.
The researchers report in the Dec. 16 issue of Cell Host & Microbe that Staphylococcus aureus (staph) favors human hemoglobin – the oxygen-carrying protein that contains iron – over hemoglobin from other animals. The findings help explain why staph preferentially infects people and suggest that genetic variations in hemoglobin ...
2010-12-16
STANFORD, Calif. — More than 2,000 genetic regions involved in early human development have been identified by researchers at the Stanford University School of Medicine. The regions, called enhancers, are responsible for triggering the expression of distant genes when embryonic stem cells begin to divide to form the many tissues of a growing embryo.
"This is going to be an enormous resource for researchers interested in tracking cells involved in early human development," said Joanna Wysocka, PhD, assistant professor of developmental biology and of chemical and systems ...
2010-12-16
LA JOLLA, CA-In addition to fast food, desk jobs, and inertia, there is one more thing to blame for unwanted pounds-our genome, which has apparently not caught up with the fact that we no longer live in the Stone Age.
That is one conclusion drawn by researchers at the Salk Institute for Biological Studies, who recently showed that mice lacking a gene regulating energy balance are protected from weight gain, even on a high fat diet. These findings have implications for the worldwide obesity epidemic and its consequences, such as type two diabetes.
In the December 16, ...
2010-12-16
The software tool presents data visually and this allows those without specialist training – both professionals and older people – to better understand and contribute to discussions about the mechanics of movement, known as biomechanics, when carrying out everyday activities.
The software takes motion capture data and muscle strength measurements from older people undertaking everyday activities. The software then generates a 3D animated human stick figure on which the biomechanical demands of the activities are represented visually at the joints. These demands, or stresses, ...
2010-12-16
A newly published insight into the biology of many kinds of less-aggressive but still lethal brain tumors, or gliomas, opens up a wide array of possibilities for new therapies, according to scientists at Brown University and the University of California, San Francisco (UCSF). In paper published online Dec. 15 in the Journal of the National Cancer Institute, they describe how a genetic mutation leads to an abnormal metabolic process in the tumors that could be targeted by drug makers.
"What this tells you is that there are some forms of tumors with a fundamentally altered ...
2010-12-16
Richmond, Va. (Dec. 15, 2010) – Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
The study, published in the journal ...
2010-12-16
Absence makes your heart grow fonder, but close-quarters may boost your career.
According to new research by scientists at Harvard Medical School, the physical proximity of researchers, especially between the first and last author on published papers, strongly correlates with the impact of their work.
"Despite all of the profound advances in information technology, such as video conferencing, we found that physical proximity still matters for research productivity and impact," says Isaac Kohane, the Lawrence J. Henderson Professor of Pediatrics at Children's Hospital ...
2010-12-16
A small-scale University of California, San Francisco-led study has identified the first evidence in humans that exposure to bisphenol A (BPA) may compromise the quality of a woman's eggs retrieved for in vitro fertilization (IVF). As blood levels of BPA in the women studied doubled, the percentage of eggs that fertilized normally declined by 50 percent, according to the research team.
The chemical BPA, which makes plastic hard and clear, has been used in many consumer products such as reusable water bottles. It also is found in epoxy resins, which form a protective ...
LAST 30 PRESS RELEASES:
[Press-News.org] deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
Analysis of 4 SNPs, in tandem with genetic risk factors detected by the deCODE ProstateCancer test, yields substantial improvement in efficacy of PSA screening
